ManhattanLife ’s Post

#TheSundayRead! 📖 Comparison of Clinical and Radiological Outcomes Between Different (Balloon) Guide Catheter With and Without Inflated Balloon in Acute Ischemic #Stroke Patients: A MaSQ-Registry Study https://lnkd.in/dmQNmmqH #OpenAccess 🔓

𝐈𝐬 𝐀𝐥𝐩𝐡𝐚-𝟏 𝐀𝐧𝐭𝐢𝐭𝐫𝐲𝐩𝐬𝐢𝐧 𝐫𝐞𝐩𝐥𝐚𝐜𝐞𝐦𝐞𝐧𝐭 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐚𝐧 𝐞𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞? During #Alpha1Awareness Month, we reflect on the #challenges #patients face: #equitableaccess to #treatment and #qualityoflife. Currently, #AAT therapy is not on the EMA’s list of #criticalmedicines and additionally #concerns are raised about future #availability due to reliance on U.S. #plasma exports and limited #European #selfsufficiency. 🏥 Special thanks to Albert Farrugia, plasma therapy scientific expert and member of our Advisory Board, for his in-depth analysis 👉 https://lnkd.in/eWE954eW At Lovexair, we work tirelessly to ensure the voices of those with respiratory conditions & complex rare diseases are heard 💪 Alfons M. Viñuela #Alpha1Awareness hashtag #RespiratoryHealth hashtag #HealthEquity hashtag #JuntosPorLaSaludRespiratoria

🔴 Recognizing World Thalassemia Day - Enhancing Care With Medical Technology 🔴 Yesterday marked World Thalassemia Day, a vital occasion to raise awareness and reflect on the impact of this genetic blood disorder. At Three Stars Medical Supplies, we stand committed to enhancing the lives of thalassemia patients through advanced life-saving medical technologies accessible and affordable globally. Our role in distributing state-of-the-art-medical devices - ranging from sophisticated blood analyzers, to efficient infusion systems-is more than a business commitment; it's designed to improve the quality of life for those managing this challenging genetic disorder. On this significant day, we celebrate our role as we continue our efforts, we dedicating in improving patient outcomes and easing the burden of thalassemia through innovation in healthcare technology. Let's keep pushing forward, making each day better for those affected by thalassemia. 🌏 💉 #WorldThalassemiaDay #Thalassemia #threestars #medicaldevices #healthcareinnovation #PatientCare #FightThalassemiaTogether

Our latest publication in the Journal of Clinical Case Reports and Images sheds light on a rare yet impactful phenomenon: Rapid Calcification of Myocardium as a Sequela from Severe Sepsis. 🫁 Our study delves into the dynamic development of myocardial calcification within just 10 weeks in a 60-year-old male patient battling severe sepsis. 📚 This peer-reviewed open access journal article uncovers the potential link between severe sepsis and myocardial calcification, offering crucial insights into its pathogenesis. Our patient, undergoing palliative therapy for multiple myeloma, experienced a pneumogenic sepsis, leading to unexpected calcifications in the left ventricle's outer myocardial layers. 🔍 Explore the full study to understand the implications of this discovery and its significance in clinical practice. Dive deep into the intricate details of our findings and contribute to the ongoing discussion on this intriguing topic. 💡 🔗 Read the full article here: https://lnkd.in/gjEaKkVe #Research #MedicalScience #MyocardialCalcification #Sepsis #ClinicalCaseReports #OpenAccessJournal

⌛Register for this webinar before time runs out⌛ Autoimmune patients face intricate health challenges, often dealing with multiple conditions simultaneously. It's a journey filled with concern for their present and future well-being, both for patients and clinicians. ⭐ Dive into a 90-minute masterclass with clinical naturopath and fx Medicine ambassador Emma Sutherland. Gain insights into her clinical practice secrets, simplifying assessment and treatment of complex autoimmunity. In this session, Emma will discuss: 📚 Her holistic approach to complex cases 🚙 Key drivers of autoimmune disease 🔍 Strategies for correct assessment and diagnosis for patients 🤝 Successful approaches for improving patient compliance 🌱 Methods for achieving better health outcomes Discover how to streamline your approach, tailor patient care, and explore effective treatment options. 👉 Grab Your Ticket Now! Secure your spot through the link below 👇 https://bit.ly/4cWYB7b #fxmedicine #clinicalmastery #autoimmune #immunity #microbiome #stress #detoxification #cpe #cpd #naturopath #naturopathic #BioCeuticals

Thrilled to share our latest research: "Interferon Therapy in Alpha and Delta Variants of SARS-CoV-2: Laboratory Success vs. Clinical Realities." 📄 Key Highlights: Insights into interferon therapy’s role against COVID-19 variants. Challenges in translating lab success into clinical effectiveness. Implications for future antiviral strategies. Download the full article below and share your thoughts—let's advance the conversation on innovative treatments! https://lnkd.in/eytW-yiy #COVID19 #InterferonTherapy #SARSCoV2 #VirologyResearch #HealthcareInnovation

🌟 Did you know that around 50% of #TAVI patients have coronary artery disease? The NOTION-3 trial aims to shed light on risk stratification and the potential need for revascularization in stable #CAD patients before TAVI procedures. Join Mamas Mamas and Jacob Thomsen Lønborg in a discussion shared by TCTMD, where they explore the implications of these findings for clinical practice and patient care. Don't miss it! 🔗 https://loom.ly/bobdOR0

Transforming the way we approach fatty liver disease isn't just about better diagnostics—it's about redefining patient care for a healthier tomorrow. 🌟 The shift from NAFLD to MAFLD in medical terminology not only marks a pivotal change in our understanding but also highlights the critical role of metabolic dysfunction in this condition, underlining the importance of personalized treatment strategies. At Arrow Dx, we're not just diagnosing fatty liver disease early; we're tailoring interventions to individual metabolic profiles, pioneering a future where care is as unique as each patient's DNA. 🧬💡 This terminology change from NAFLD to MAFLD is not just semantic; it signifies a deeper comprehension of the disease and a more focused approach to treatment. Dive deeper into how biotech innovations are paving the way for personalized medicine in our latest blog. Read now: https://lnkd.in/edAvAiqc #FattyLiverDisease #PersonalizedMedicine #ArrowDxInnovation

📚 Our read comes from the Journal of Public Health International, shedding light on COX-2 inhibitors and NSAID hypersensitivity. 🩺💊 This peer-reviewed study delves into cross-reactivity between these inhibitors, crucial for patient safety and alternative treatment options. 🔍 Key Findings: Cross-Reactivity: The study explores the cross-reactivity between COX-2 inhibitors in patients with NSAID hypersensitivity. Patient Safety: Meloxicam, nimesulide, and celecoxib emerged as safe alternatives for those with cross-reactive phenotypes. Tolerability: While celecoxib showed the most favorable tolerability, cross-reactivity among COX-2 inhibitors remains a possibility. 📰 Dive deeper into this fascinating research: https://lnkd.in/g7UN_b2z #COX2Inhibitors #NSAIDHypersensitivity #MedicalScience #PeerReviewedStudy Stay informed, stay curious! 🧠💡

Histoplasmosis misdiagnosed as malignancies in immunocompetent and immunocompromised patients: A global perspective on clinical presentation, radiological and pathological findings https://lnkd.in/eDiYVMqc